These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 20105183)
1. Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands. Baker JG; Middleton R; Adams L; May LT; Briddon SJ; Kellam B; Hill SJ Br J Pharmacol; 2010 Feb; 159(4):772-86. PubMed ID: 20105183 [TBL] [Abstract][Full Text] [Related]
2. Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactions. May LT; Briddon SJ; Hill SJ Mol Pharmacol; 2010 Apr; 77(4):678-86. PubMed ID: 20086038 [TBL] [Abstract][Full Text] [Related]
3. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells. Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651 [TBL] [Abstract][Full Text] [Related]
4. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP; Curtis AR; Kendall DA; Hill SJ Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308 [TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist. Baker JG; Hall IP; Hill SJ Br J Pharmacol; 2003 May; 139(2):232-42. PubMed ID: 12770928 [TBL] [Abstract][Full Text] [Related]
7. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Gherbi K; Briddon SJ; Hill SJ Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258 [TBL] [Abstract][Full Text] [Related]
8. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake. Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526 [TBL] [Abstract][Full Text] [Related]
9. Role of the second transmembrane domain of rat adenosine A1 receptor in ligand-receptor interaction. Xie KQ; Cao Y; Zhu XZ Biochem Pharmacol; 2006 Mar; 71(6):865-71. PubMed ID: 16414025 [TBL] [Abstract][Full Text] [Related]
10. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor. Baker JG; Proudman RG; Tate CG Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells. Briddon SJ; Middleton RJ; Cordeaux Y; Flavin FM; Weinstein JA; George MW; Kellam B; Hill SJ Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4673-8. PubMed ID: 15070776 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors. Baker JG; Adams LA; Salchow K; Mistry SN; Middleton RJ; Hill SJ; Kellam B J Med Chem; 2011 Oct; 54(19):6874-87. PubMed ID: 21870877 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1-receptor. Baker JG; Hill SJ J Pharmacol Exp Ther; 2007 Jan; 320(1):218-28. PubMed ID: 17018691 [TBL] [Abstract][Full Text] [Related]
14. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261. Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373 [TBL] [Abstract][Full Text] [Related]
15. Effects of urea pretreatment on the binding properties of adenosine A1 receptors. May LT; Sexton PM; Christopoulos A Br J Pharmacol; 2005 Dec; 146(8):1119-29. PubMed ID: 16231004 [TBL] [Abstract][Full Text] [Related]
16. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity. Stewart GD; Valant C; Dowell SJ; Mijaljica D; Devenish RJ; Scammells PJ; Sexton PM; Christopoulos A J Pharmacol Exp Ther; 2009 Oct; 331(1):277-86. PubMed ID: 19641164 [TBL] [Abstract][Full Text] [Related]
17. 7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors. Macchia M; Salvetti F; Bertini S; Di Bussolo V; Gattuso L; Gesi M; Hamdan M; Klotz KN; Laragione T; Lucacchini A; Minutolo F; Nencetti S; Papi C; Tuscano D; Martini C Bioorg Med Chem Lett; 2001 Dec; 11(23):3023-6. PubMed ID: 11714602 [TBL] [Abstract][Full Text] [Related]
18. Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist. Stoddart LA; Vernall AJ; Briddon SJ; Kellam B; Hill SJ Neuropharmacology; 2015 Nov; 98():68-77. PubMed ID: 25937210 [TBL] [Abstract][Full Text] [Related]
19. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent probes for adenosine receptors: synthesis and biology of N6-dansylaminoalkyl-substituted NECA derivatives. Macchia M; Salvetti F; Barontini S; Calvani F; Gesi M; Hamdan M; Lucacchini A; Pellegrini A; Soldani P; Martini C Bioorg Med Chem Lett; 1998 Nov; 8(22):3223-8. PubMed ID: 9873707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]